ArticlePloS one2016

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection.

Brian D Lehmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.